Market Place
Sourcing Support
Catalyst Announces Completion of Business Combination With Beijing Continent
30 Oct 2023 //
GLOBENEWSWIRE
Catalyst Clinical Research Acquires Genpro Research
21 Jul 2023 //
CONTRACT PHARMA
Catalyst Global Announces New Board Member Dr. Jotham Musinguzi
27 Mar 2023 //
ACCESSWIRE
GC Biopharma to Acquire Catalyst Biosciences Rare Disease Hematology Pipeline
02 Mar 2023 //
CONTRACT PHARMA
Catalyst Biosciences Provides Corporate Update
28 Feb 2023 //
GLOBENEWSWIRE
GC Biopharma Signs Agreement with Catalyst Biosciences
27 Feb 2023 //
PR NEWSWIRE
Catalyst Receives FDA 510(k) Clearance for its Arthroplasty System
09 Feb 2023 //
BUSINESSWIRE
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
27 Dec 2022 //
GLOBENEWSWIRE
Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share
25 Aug 2022 //
GLOBENEWSWIRE
Catalyst Biosciences, Inc. Announces Dismissal of JDS1 Litigation
19 Aug 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Announces Withdrawal of JDS1 Nominations to the Board
10 Aug 2022 //
GLOBENEWSWIRE
Leading Independent Proxy Advisory Firms ISS and Glass Lewis
03 Aug 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Announces Support from Largest Single Stockholder
01 Aug 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Comments on Favorable Delaware Court of Chancery Ruling
06 Jul 2022 //
GLOBENEWSWIRE
Catalyst Biosciences prepares to call it quits
30 Jun 2022 //
ENDPTS
Group of Catalyst shareholders claims biotech could’ve sold assets 3 years ago
27 May 2022 //
ENDPTS
Vertex scoops up Catalyst’s complement pipeline for $60M cash
26 May 2022 //
FIERCEBIOTECH
Catalyst Biosciences Sells Complement Portfolio for $60 Million
23 May 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
09 May 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Reports Q4 and Year-end 2021 Operating & Financial Results
31 Mar 2022 //
GLOBENEWSWIRE
Catalyst Bio Regains Rights to CB 2782-PEG for dry AMD
15 Mar 2022 //
GLOBENEWSWIRE
Catalyst Biosciences Receives RPD Designation for CB 4332 in CFI Deficiency
25 Jan 2022 //
GLOBENEWSWIRE
Ampio Pharmaceuticals CEO passes baton to a new board member; & more
24 Nov 2021 //
ENDPTS
Catalyst Biosciences to Present at the Piper Sandler 33rd AVHC
22 Nov 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Announces Chief Financial Officer Transition
13 Oct 2021 //
GLOBENEWSWIRE
FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA
28 Sep 2021 //
GLOBENEWSWIRE
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
24 Sep 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
15 Sep 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Appoints Jeanne Jew to its Board of Directors
08 Sep 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results
05 Aug 2021 //
GLOBENEWSWIRE
Catalyst 1st Patient Screen CFI, CB 4332 Screen Natural History Disease
22 Jul 2021 //
GLOBENEWSWIRE
Catalyst 1st Patient Screen CFI, CB 4332 Screen Natural History Disease
22 Jul 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Presents Four Posters at the ISTH 2021 Virtual Congress
19 Jul 2021 //
GLOBENEWSWIRE
Catalyst Announces Key Leadership Changes in its Ongoing Transition
14 Jul 2021 //
GLOBENEWSWIRE
Pfizer, Zogenix, Catalyst, Rigel raise prices to start July
01 Jul 2021 //
FIERCEPHARMA
Catalyst Biosciences to Host R&D Day on CB 4332 and Complement Programs
01 Jul 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA
28 Jun 2021 //
GLOBENEWSWIRE
Catalyst, Inc.`s and KYE Pharmaceuticals` Lawsuit in Canadian Federal Court
03 Jun 2021 //
NEWSWIRE
Catalyst Announces First Patient Dosed in Marzeptacog Alfa (Activated)
18 May 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene
19 Apr 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Expands its Protease Medicines Patent Portfolio
13 Apr 2021 //
GLOBNEWSWIRE
Catalyst Presents Pre-clinical SQ of Bleeds Data from its Marzeptacog alfa
03 Feb 2021 //
GLOBENEWSWIRE
Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd ASH
07 Dec 2020 //
GLOBENEWSWIRE
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous
02 Dec 2020 //
GLOBENEWSWIRE
Catalyst Announces Poster Presentation at the 62nd Annual ASH
05 Nov 2020 //
GLOBENEWSWIRE
Catalyst to appeal ruling in favor of FDA decision on Firdapse`s competitor drug
30 Sep 2020 //
SEEKING ALPHA
Catalyst Biosciences Presents At Morgan Stanley Global Healthcare Conference
18 Sep 2020 //
SEEKING ALPHA
Upcoming market catalysts in Q4 2020
10 Sep 2020 //
NATURE
Judge Recommends Throwing Out Catalyst’s Suit Against FDA
04 Aug 2020 //
FDANEWS
Catalyst Comments on Magistrate Judge`s Report & Recommendation in its Lawsuit
31 Jul 2020 //
GLOBENEWSWIRE
Catalyst Presents Data at the International Society for (ISTH) Virtual Congress
15 Jul 2020 //
GLOBENEWLSWIRE
Early Data Support Catalyst Biosciences’ Potential Hemophilia B Gene Therapy
08 Jul 2020 //
HEMOPHILIANEWSTODAY
Catalyst Biosciences Announces Presentations at the International Society
29 Jun 2020 //
GLOBENEWSWIRE
Catalyst Biosciences Presents +VE Final Data from PH2b Trial Dalcinonacog Alfa
15 Jun 2020 //
GLOBENEWSWIRE
Catalyst Biosciences Completes MarzAA Pharmacokinetic & Pharmacodynamic Study
10 Jun 2020 //
GLOBENEWSWIRE
Catalyst Announces Oral and Poster Presentations at the World Federation
08 Jun 2020 //
GLOBENEWSWIRE
Catalyst Biosciences Receives Patent in the EU Union for Its Factor IX Portfolio
28 Apr 2020 //
MARKETWATCH
Catalyst Biosciences Completes Phase 2b Trial of Subcutaneous
21 Apr 2020 //
GLOBENEWSWIRE
